/TECX

Tectonic Therapeutic Inc

TECX

$29.05USD↑+1.54%+0.44 today

MARKET CAP

567.9M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$29 – $29

52W RANGE

$14

$40

AI Summary

Stalk

StalkMedium

In a Stage 2 advance with higher highs and higher lows intact, medium- and long-term biases remain bullish, supported by rising EMAs and constructive volume. Short-term price is churning around flat-to-rising 9/21 and 50 EMAs without a clear directional edge, so we defer execution. We will look to buy on a decisive pullback into the EMA cluster or on a breakout above recent consolidation.

↑Strong Buy ratings with $79.40 average target and $101 high imply ~148% upside.
↑High institutional interest (elevated 13F holdings) signals confidence in pipeline value.
↓Q1 EPS of ‑$1.34 and $44.7M FCF burn strain cash runway.

Full analysis →

Buying

6

institutions

Selling

4

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	862.59 K	29.65 M	+2.24 K	+11.5%	0.00%
MM Millennium Management LLC Q2 2026	BUY	165.53 K	5.69 M	+107.18 K	+215.5%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	107.39 K	3.69 M	+54.99 K	+127.9%	0.00%
WP Woodline Partners LP Q2 2026	SELL	100.00 K	3.44 M	+-100.00 K	-44.4%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	55.36 K	1.83 M	+-3.51 K	+7.8%	0.00%
FA Fisher Asset Management, LLC Q2 2026	BUYNEW	19.12 K	657.32 K	+19.12 K	+0.0%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	BUY	14.50 K	498.47 K	+1.50 K	+24.0%	0.02%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	9.57 K	329.07 K	+9.57 K	+0.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	6.62 K	227.46 K	+-10.32 K	-56.5%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-68.60 K	-100.0%	0.00%